Paste your Google Webmaster Tools verification code here
Indian pharma major Dr. Reddy’s announced that it has collaborated with Turkey based TR-Pharm involving three biosimilar products. Dr. Reddy’s said in a statement that “We have entered into a strategic collaboration agreement with Turkey-based TRPharm involving 3 biosimilar products. These products will be registered and subsequently commercialized as a part of this agreement by TR-Pharm in Turkey”.
Under the strategic agreement, TR-Pharm would also manufacture the drug substance and drug product upon completion of its facility investment. It would also prove an important component of TR-Pharm’s ongoing biological product development and manufacturing business in the region and the company has already begun laying out the groundwork for the technology transfer.
Read More: Biotecnika Magazine | April 2016
Shekhar Suman is a Serial Entrepreneur and the Co-Founder of Biotecnika. Magazine is a way he wants to recraft the way industry opines and expresses its views. With years of experience under his belt, he captains the ship with prudence and perfection. He is the chief-editor of Biotecnika Magazine and a big inspiration to the bio-community.
Your email address will not be published. Required fields are marked *
Notify me of follow-up comments by email.
Notify me of new posts by email.
biutech is one of the best field for human civilisatin.human now a day ...
Please help me through biotech daily updates ...
"We cannot turn back the clock on agriculture and only use methods tha ...
That is a good tip particularly to those fresh to the blogosphere. Br ...
Marvelous, what a website it is! This blog provides helpful data to us ...
Budget 2016 | What is in store for life science industry?
MONSANTO – INDIA SPAT | would it risk GM prevalence in the country?
Dr. Reddy’s and TR-Pharm collaborate over BIOSIMILARS
Person-on-chip for better drug testing
Scientists pin point gene that makes you grey
2014 Powered By Wordpress, Goodnews Theme By Momizat Team